X-Site Seeks Financing, Possible Partner For Vascular Closure System Launch
This article was originally published in The Gray Sheet
Executive Summary
X-Site Medical is pursuing additional financing to support commercialization of its recently approved X-Press 6 Fr. vascular closure system
You may also be interested in...
Abbott StarClose Opens Vascular Closure Options; U.S. Launch Set For 2005
Abbott believes its StarClose vascular closure device will represent a competitive alternative to St. Jude's market leading AngioSeal upon U.S. approval in 2005
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.